Cytek Biosciences, Inc. Quarterly Goodwill in USD from Q4 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Cytek Biosciences, Inc. quarterly Goodwill history and growth rate from Q4 2020 to Q2 2025.
  • Cytek Biosciences, Inc. Goodwill for the quarter ending June 30, 2025 was $16.7M, a 3.24% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $16.7M +$524K +3.24% Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $16.7M +$495K +3.06% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $16.7M +$480K +2.97% Dec 31, 2024 10-Q 2025-08-06
Q3 2024 $16.2M -$274K -1.67% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $16.2M -$2.96M -15.5% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $16.2M -$2.96M -15.5% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $16.2M +$6.04M +59.5% Dec 31, 2023 10-K 2025-02-28
Q3 2023 $16.5M +$6.31M +62.2% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $19.1M +$9M +88.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $19.1M +$9M +88.7% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $10.1M $0 0% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $10.1M +$9.67M +2031% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $10.1M +$9.67M +2031% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $10.1M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $10.1M +$9.67M +2031% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $476K Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $476K Jun 30, 2021 10-Q 2021-09-03
Q4 2020 $476K Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.